title: Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
abstract: Inherited and acquired factors have been implicated in the pathogenesis of porphyria cutanea tarda (PCT), a disorder characterized by a photosensitive dermatosis and hepatic siderosis. This study, comprising 108 patients with PCT, was intended to define the role of hemochromatosis gene (HFE) mutations in the expression of PCT and to determine the contribution of acquired factors including alcohol, hepatitis C virus (HCV), and estrogen. The 2 known HFE mutations, cysteine 282 tyrosine (Cys282Tyr) and histidine 63 asparagine (His63Asp), were detected by polymerase chain reaction, and anti-HCV immunoglobulin G was detected serologically. Liver biopsies were graded for iron content, inflammation, and fibrosis. Estimates of alcohol and estrogen use were based on a questionnaire. Of the PCT patients tested, 19% were homozygous for the Cys282Tyr mutation; controls were equal to 0.5%. The compound heterozygous genotype was detected in 7% of the PCT patients; controls were less than 1%. The transferrin saturation, serum ferritin, and liver iron burden of all PCT patients were higher than those of nonporphyric controls. The highest values were found in PCT patients homozygous for the Cys282Tyr mutation. Of the patients studied, 59% were HCV positive (compared with 1.8% of the population), and 46% consumed more than 70 g of alcohol daily. Of the female patients, 63% were ingesting estrogens. Hepatic damage was most marked in patients with the Cys282Tyr/Cys282Tyr genotype who had HCV and drank heavily. Homozygosity for the Cys282Tyr mutation and HCV are the greatest risk factors for expression of PCT, and in most patients, more than 1 risk factor was identified. It was common for patients with HCV to consume alcohol. Patients with PCT should be screened for HFE mutations and for HCV. (Blood. 2000;95:1565-1571)
authors.affiliation: Departments of Medicine, Pharmacology, and Pathology, the University of Utah School of Medicine, and the Latter Day Saints Hospital, Salt Lake City, UT, USA.
authors.forename: Z J
authors.initials: ZJ
authors.lastname: Bulaj
authors.forename: J D
authors.initials: JD
authors.lastname: Phillips
authors.forename: R S
authors.initials: RS
authors.lastname: Ajioka
authors.forename: M R
authors.initials: MR
authors.lastname: Franklin
authors.forename: L M
authors.initials: LM
authors.lastname: Griffen
authors.forename: D J
authors.initials: DJ
authors.lastname: Guinee
authors.forename: C Q
authors.initials: CQ
authors.lastname: Edwards
authors.forename: J P
authors.initials: JP
authors.lastname: Kushner
mesh_terms: D000293:Adolescent; D000328:Adult; D000428:Alcohol Drinking / Q000453:epidemiology; D001706:Biopsy; D002675:Child, Preschool; D015897:Comorbidity; D004967:Estrogens / Q000009:adverse effects / Q000502:physiology; D005260:Female; D005293:Ferritins / Q000097:blood; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005838:Genotype; D006432:Hemochromatosis / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D006526:Hepatitis C / Q000453:epidemiology; D006801:Humans; D007501:Iron / Q000032:analysis; D008099:Liver / Q000737:chemistry / Q000473:pathology; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D017119:Porphyria Cutanea Tarda / Q000453:epidemiology / Q000209:etiology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D014168:Transferrin / Q000032:analysis
chemical_list: D004967:Estrogens; D014168:Transferrin; D005293:Ferritins; D007501:Iron